SynthesisNeuro-oncology2021

MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review.

Sebastian Brandner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.